← SynDRA
BAFILOMYCIN A1
SynDRA canonical compound SYN0002065 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | ATP2A1 | ATP6V1A |
| Mechanism of action | ATPase inhibitor |
All known targets
Mechanisms of action (all sources)
Drug classes
- Antifungal Agents
- Enzyme Inhibitors
Cross-references
Synonyms
- MFCD06795130
- CHEMBL290814
- CHEBI:22689
- (3Z,5E,7R,8S,9S,11E,13E,15S,16R)-16-{(2S,3R,4S)-4-[(2R,4R,5S,6R)-2,4-dihydroxy-6-isopropyl-5-methyltetrahydro-2H-pyran-2-yl]-3-hydroxypentan-2-yl}-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyloxacyclohexadeca-3,5,11,13-tetraen-2-one
- Bafilomycin
- NSC381866
- Bafilomycin A1/
- Hygrolidin, 21-O-de(3-carboxy-1-oxo-2-propenyl)-2-demethyl-2-methoxy-24-methyl-
- Bafilomycin A1 from Streptomyces griseus
- BSPBio_001470
- MEGxm0_000385
- SCHEMBL13775181
- ACon0_000813
- HMS3402J12
- Bafilomycin A1 Ready Made Solution
- ABP000610
- BDBM50064186
- AKOS030213158
- ZINC169647947
- DB06733
- MCULE-2359469972
- NCGC00163426-02
- (3Z,5E,7R,8S,9S,11E,13E,15S,16R)-16-[(2S,3R,4S)-4-[(2R,4R,5S,6R)-2,4-dihydroxy-5-methyl-6-propan-2-yloxan-2-yl]-3-hydroxypentan-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one
- Q4841341
- (3Z,5E,7R,8S,9S,11E,13E,15S,16R)-16-[(1S,2R,3S)-3-[(2R,4R,5S,6R)-2,4-dihydroxy-6-isopropyl-5-methyl-tetrahydropyran-2-yl]-2-hydroxy-1-methyl-butyl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one
- RefChem:116316
- DTXCID201534072
- BafA1
- C35H58O9
- orb1300510
- XDHNQDDQEHDUTM-JQWOJBOSSA-N
- HB1125
- AT13632
- EBC-615518
- FB146475
- T6740
- F860597
- bafilomycin
Look up BAFILOMYCIN A1 in the interactive SynDRA portal →